Literature DB >> 27020133

Costs of Antimicrobial Stewardship Programs at US Children's Hospitals.

Philip Zachariah1, Jason G Newland2, Jeffrey S Gerber3, Lisa Saiman1, Jennifer L Goldman2, Adam L Hersh4.   

Abstract

The costs of antimicrobial stewardship programs (ASPs) in children's hospitals have not been described previously. We assessed ASP costs using an online survey administered to ASP leaders at U.S. children's hospitals. ASP costs varied from $17,000 to $388,500 annually (median, $187,400). Overall costs were not correlated with hospital size. Infect Control Hosp Epidemiol 2016;37:852-854.

Entities:  

Mesh：

Year:  2016        PMID： 27020133      PMCID： PMC5051263          DOI： 10.1017/ice.2016.62

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  7 in total

1.  Antimicrobial stewardship: shepherding precious resources.

Authors:  Robert C Owens; Andrew F Shorr; Andrea L Deschambeault
Journal:  Am J Health Syst Pharm       Date:  2009-06-15       Impact factor: 2.637

2.  A World Wide Web-based antimicrobial stewardship program improves efficiency, communication, and user satisfaction and reduces cost in a tertiary care pediatric medical center.

Authors:  Allison L Agwu; Carlton K K Lee; Sanjay K Jain; Kara L Murray; Jason Topolski; Robert E Miller; Timothy Townsend; Christoph U Lehmann
Journal:  Clin Infect Dis       Date:  2008-09-15       Impact factor: 9.079

Review 3.  Antimicrobial stewardship in pediatrics: how every pediatrician can be a steward.

Authors:  David Y Hyun; Adam L Hersh; Katie Namtu; Debra L Palazzi; Holly D Maples; Jason G Newland; Lisa Saiman
Journal:  JAMA Pediatr       Date:  2013-09       Impact factor: 16.193

4.  Sustained savings from a longitudinal cost analysis of an internet-based preapproval antimicrobial stewardship program.

Authors:  Anna C Sick; Christoph U Lehmann; Pranita D Tamma; Carlton K K Lee; Allison L Agwu
Journal:  Infect Control Hosp Epidemiol       Date:  2013-04-18       Impact factor: 3.254

5.  Prevalence and characteristics of antimicrobial stewardship programs at freestanding children's hospitals in the United States.

Authors:  Jason G Newland; Jeffrey S Gerber; Scott J Weissman; Samir S Shah; Chelsea Turgeon; Erin B Hedican; Cary Thurm; Matt Hall; Joshua Courter; Thomas V Brogan; Holly Maples; Brian R Lee; Adam L Hersh
Journal:  Infect Control Hosp Epidemiol       Date:  2014-01-24       Impact factor: 3.254

6.  Antimicrobial stewardship programs in freestanding children's hospitals.

Authors:  Adam L Hersh; Stephen A De Lurgio; Cary Thurm; Brian R Lee; Scott J Weissman; Joshua D Courter; Thomas V Brogan; Samir S Shah; Matthew P Kronman; Jeffrey S Gerber; Jason G Newland
Journal:  Pediatrics       Date:  2014-12-08       Impact factor: 7.124

7.  Evaluation of an antimicrobial stewardship program at a pediatric teaching hospital.

Authors:  Talene A Metjian; Priya A Prasad; Amy Kogon; Susan E Coffin; Theoklis E Zaoutis
Journal:  Pediatr Infect Dis J       Date:  2008-02       Impact factor: 2.129
  7 in total
  4 in total

1.  Current State of Antimicrobial Stewardship in Children's Hospital Emergency Departments.

Authors:  Rakesh D Mistry; Jason G Newland; Jeffrey S Gerber; Adam L Hersh; Larissa May; Sarah M Perman; Nathan Kuppermann; Peter S Dayan
Journal:  Infect Control Hosp Epidemiol       Date:  2017-02-08       Impact factor: 3.254

2.  Structure of Antimicrobial Stewardship Programs in Leading US Hospitals: Findings of a Nationwide Survey.

Authors:  Derrick Nhan; Eric J M Lentz; Marilyn Steinberg; Chaim M Bell; Andrew M Morris
Journal:  Open Forum Infect Dis       Date:  2019-04-06       Impact factor: 3.835

3.  Antibiotic prescriptions in acute otitis media and pharyngitis in Italian pediatric outpatients.

Authors:  E Barbieri; D Donà; A Cantarutti; R Lundin; A Scamarcia; G Corrao; L Cantarutti; C Giaquinto
Journal:  Ital J Pediatr       Date:  2019-08-17       Impact factor: 2.638

4.  The economics of managing evolution.

Authors:  Troy Day; David A Kennedy; Andrew F Read; David McAdams
Journal:  PLoS Biol       Date:  2021-11-16       Impact factor: 8.029
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.